Back to STATE STREET CORP STATE STREET CORP

IBRXIBRX
Showing 8 of 10 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in IMMUNITYBIO INC

STATE STREET CORP holds 17.7M shares of IBRX (IMMUNITYBIO INC), worth $135.8M as of 2026-Q1. The position was increased (+7.6% shares). IBRX represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$135.8M

Current Shares

17.7M

Total Value Change

+$86.1M

Total Shares Change

+9.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
17.7M
+7.6%
$135.8M0.0%$10.00
33
2025-Q4
Increased
16.5M
+45.4%
$32.6M0.0%$1.98
39
2025-Q3
Increased
11.3M
+48.6%
$27.8M0.0%$2.57
40
2025-Q2
Increased
7.6M
+0.4%
$20.1M0.0%$2.70
28
2025-Q1
Decreased
7.6M
-22.5%
$22.8M0.0%$3.14
0
2024-Q4
Increased
9.8M
+13.1%
$25.1M0.0%$2.68
32
2024-Q3
Increased
8.7M
+10.1%
$32.2M0.0%$3.93
32
2024-Q2
Decreased
7.9M
-44.6%
$49.7M0.0%$6.32
0

Other major holders of IBRX: BlackRock, Inc., VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC, D. E. Shaw & Co., Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used